Journal
BLOOD
Volume 104, Issue 2, Pages 420-427Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2003-08-2881
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL 50744-02] Funding Source: Medline
Ask authors/readers for more resources
The glycoprotein Ib-V-IX (GPIb-V-IX) complex interacts with subendothelial von Willebrand factor (VWF) to ensure recruitment of platelets at sites of vascular injury, a process that culminates in integrin alpha(IIb)beta(3)-dependent stable adhesion and spreading. Interaction of the 114-3-3zeta adaptor protein with the C-terminal 606-610 phosphoserine motif of the GPIbalpha subunit has been implicated in the control of 00103 activation and cell spreading. in this study, we have examined potentially novel 114-3-3zeta binding sites by expressing mutant forms of GPIbalpha in Chinese-hamster-ovary (CHO) cells. Analysis of a series of neighboring 11-12 residue deletions identified a critical role for the 580-LVAGRRPSALS-590 sequence in promoting GPIbalpha-114-3-3zeta interaction. Development of a phosphospecific antibody demonstrated high levels of phosphorylation of the Ser587 and Ser590 residues in resting platelets (which became dephosphorylated during platelet spreading on VWF), and peptides containing these phosphorylated residues effectively displaced 14-3-3zeta from GPIbalpha. Analysis of single and double alanine substitutions of Ser587 and Ser590 demonstrated a major role for these residues in promoting GPIbalpha-114-3-3zeta binding. Moreover, these cell lines exhibited a defect in cell spreading on immobilized VWF, These studies demonstrate the existence of a second major 114-3-3zeta binding site within the cytoplasmic tall of GPIbalpha that has an important functional role in regulating integrin-dependent cell spreading.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available